ALDH1A3 and breast carcinoma: In breast cancer patient datasets (TCGA, Cell 2015 and METABRIC), expression of ABAT was negatively correlated (Fig. 6C) while expression of GABRE was positively correlated (Fig. D) with ALDH1A3 expression, consistent with the MDA-MB-231 data (Fig. 6B).